We are live on
!
Find out more
MIM
MetLife Investment Management Portfolio holdings
AUM
$19.6B
1-Year Est. Return
32.64%
This Fund
S&P 500
This Quarter
Est. Return
-2.49%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$12.8B
AUM Growth
-$896M
(-6.5%)
Cap. Flow
-$396M
Cap. Flow
% of AUM
-3.08%
Top 10 Holdings %
Top 10 Hldgs %
24.99%
Holding
3,035
New
97
Increased
329
Reduced
999
Closed
146
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$37.9M |
| 2 |
Blackstone
BX
|
+$16.9M |
| 3 |
Airbnb
ABNB
|
+$13.4M |
| 4 |
Kenvue
KVUE
|
+$10.4M |
| 5 |
CIVI
Civitas Resources
CIVI
|
+$7.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$125M |
| 2 |
Accenture
ACN
|
+$57.6M |
| 3 |
Medtronic
MDT
|
+$28M |
| 4 |
Apple
AAPL
|
+$21.2M |
| 5 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$19.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.12% |
| 2 | Healthcare | 12.03% |
| 3 | Financials | 11.49% |
| 4 | Consumer Discretionary | 10.97% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
AT&T
T
$166B
| $26.6M | 0.21% |
1,768,528
-46,265
| -3% | -$678K |
|
77
Lockheed Martin
LMT
$140B
| $26.5M | 0.21% |
64,903
-1,748
| -3% | -$775K |
|
|
MRSH
78
Marsh
MRSH
$90.1B
| $26.4M | 0.21% |
138,721
-3,376
| -2% | -$647K |
|
79
Goldman Sachs
GS
$302B
| $26.3M | 0.21% |
81,411
-2,782
| -3% | -$930K |
|
80
Elevance Health
ELV
$86.6B
| $26M | 0.2% |
59,631
-1,854
| -3% | -$841K |
|
81
RTX Corp
RTX
$300B
| $25.9M | 0.2% |
360,137
-10,737
| -3% | -$920K |
|
82
Morgan Stanley
MS
$342B
| $25.7M | 0.2% |
314,124
-14,537
| -4% | -$1.26M |
|
83
Prologis
PLD
$134B
| $25.6M | 0.2% |
228,491
-5,887
| -3% | -$720K |
|
84
Vertex Pharmaceuticals
VRTX
$133B
| $25.6M | 0.2% |
73,654
-1,544
| -2% | -$540K |
|
|
85
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.2B
| $24.6M | 0.19% |
53,900
-40,200
| -43% | -$19.3M |
|
86
Lam Research
LRCX
$408B
| $24M | 0.19% |
382,830
-11,080
| -3% | -$728K |
|
87
Stryker
SYK
$133B
| $24M | 0.19% |
87,709
-2,149
| -2% | -$616K |
|
88
Mondelez International
MDLZ
$79.4B
| $23.4M | 0.18% |
336,488
-9,142
| -3% | -$659K |
|
89
Zoetis
ZTS
$30.4B
| $23.2M | 0.18% |
133,197
-3,399
| -2% | -$617K |
|
90
Gilead Sciences
GILD
$168B
| $23.1M | 0.18% |
308,279
-8,376
| -3% | -$644K |
|
91
Progressive
PGR
$121B
| $22.7M | 0.18% |
163,005
-3,794
| -2% | -$499K |
|
92
American Express
AXP
$232B
| $22.7M | 0.18% |
152,190
-6,758
| -4% | -$1.11M |
|
93
Blackrock
BLK
$180B
| $22.6M | 0.18% |
34,882
-3,111
| -8% | -$2.17M |
|
94
CVS Health
CVS
$121B
| $22.2M | 0.17% |
317,619
-7,756
| -2% | -$550K |
|
95
American Tower
AMT
$79.4B
| $22.1M | 0.17% |
134,691
-2,992
| -2% | -$546K |
|
|
96
Blackstone
BX
$110B
| $22M | 0.17% |
205,306
+161,927
| +373% | +$16.9M |
|
97
Regeneron Pharmaceuticals
REGN
$82.2B
| $21.9M | 0.17% |
26,635
-961
| -3% | -$755K |
|
98
Analog Devices
ADI
$187B
| $21.7M | 0.17% |
124,107
-4,284
| -3% | -$790K |
|
99
Cigna
CI
$73.3B
| $21.2M | 0.17% |
74,032
-1,890
| -2% | -$539K |
|
100
Chubb
CB
$132B
| $21.2M | 0.16% |
101,624
-3,464
| -3% | -$700K |
|
Similar funds
SPIA
BG
PCM
CS
HHII
LF
EIM
MetLife Investment Management's Q3 2023 Portfolio in Review
As of Q3 2023, MetLife Investment Management held 3,035 positions worth $12.8B, down 6.5% from $13.7B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
MetLife Investment Management withdrew a net $396M in Q3 2023, closing 146 positions and reducing 999 holdings. Its most notable exit was Accenture, an estimated $57.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
Against the trend, MetLife Investment Management opened a new position in Kenvue worth $9.06M.
- MetLife Investment Management's largest Q3 2023 buy was Kenvue: 451,001 shares worth $9.06M.
- MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2023, an estimated $37.9M increase.
- MetLife Investment Management's biggest Q3 2023 reduction was Vanguard Short-Term Bond ETF, cutting an estimated $125M.
- MetLife Investment Management fully exited Accenture in Q3 2023, selling an estimated $57.6M.
- MetLife Investment Management's ten largest holdings make up 25% of its $12.8B portfolio in Q3 2023.
- MetLife Investment Management opened 97 new positions and closed 146 in Q3 2023.
- MetLife Investment Management's portfolio value fell 6.5% quarter-over-quarter to $12.8B.
Based on MetLife Investment Management's 13F filing for Q3 2023, filed 14 Nov 2023.